loading
前日終値:
$1.80
開ける:
$1.78
24時間の取引高:
363.79K
Relative Volume:
0.18
時価総額:
$297.33M
収益:
$12.87M
当期純損益:
$-114.34M
株価収益率:
-2.0761
EPS:
-0.8646
ネットキャッシュフロー:
$-79.23M
1週間 パフォーマンス:
+0.84%
1か月 パフォーマンス:
-6.99%
6か月 パフォーマンス:
-4.52%
1年 パフォーマンス:
-26.73%
1日の値動き範囲:
Value
$1.755
$1.845
1週間の範囲:
Value
$1.70
$1.98
52週間の値動き範囲:
Value
$1.05
$4.32

Taysha Gene Therapies Inc Stock (TSHA) Company Profile

Name
名前
Taysha Gene Therapies Inc
Name
セクター
Healthcare (1153)
Name
電話
(214) 612-0000
Name
住所
3000 PEGASUS PARK DRIVE, DALLAS
Name
職員
73
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
TSHA's Discussions on Twitter

TSHA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TSHA
Taysha Gene Therapies Inc
1.79 297.33M 12.87M -114.34M -79.23M -0.8646
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.57 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.97 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
628.63 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
257.89 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
248.36 24.70B 3.81B -644.79M -669.77M -6.24

Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-06-27 開始されました BMO Capital Markets Outperform
2024-04-09 開始されました Piper Sandler Overweight
2023-02-01 ダウングレード Jefferies Buy → Hold
2023-01-27 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-11-09 ダウングレード Goldman Buy → Neutral
2022-03-09 開始されました Robert W. Baird Outperform
2022-03-01 開始されました Wells Fargo Overweight
2022-02-18 開始されました SMBC Nikko Outperform
2021-12-16 開始されました Guggenheim Buy
2021-07-16 開始されました Needham Buy
2021-06-24 開始されました Truist Buy
2021-06-15 開始されました BTIG Research Buy
2021-06-09 開始されました Wedbush Outperform
2021-06-08 開始されました JMP Securities Mkt Outperform
2021-05-19 開始されました Cantor Fitzgerald Overweight
2021-05-11 再開されました Jefferies Buy
2021-02-24 開始されました William Blair Outperform
2021-01-05 開始されました Oppenheimer Outperform
2020-10-19 開始されました Chardan Capital Markets Buy
2020-10-19 開始されました Goldman Buy
2020-10-19 開始されました Jefferies Buy
2020-10-19 開始されました Morgan Stanley Overweight
すべてを表示

Taysha Gene Therapies Inc (TSHA) 最新ニュース

pulisher
09:40 AM

What is Taysha Gene Therapies Inc (TSHA) Stock Return on Shareholders’ Capital? - Sete News

09:40 AM
pulisher
05:31 AM

Taysha Gene Therapies’ (TSHA) Overweight Rating Reaffirmed at Cantor Fitzgerald - Defense World

05:31 AM
pulisher
03:50 AM

Taysha Gene Therapies (NASDAQ:TSHA) Receives Market Outperform Rating from JMP Securities - Defense World

03:50 AM
pulisher
Apr 28, 2025

Understanding the Risks of Investing in Taysha Gene Therapies Inc (TSHA) - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Examining TSHA’s book value per share for the latest quarter - uspostnews.com

Apr 28, 2025
pulisher
Apr 28, 2025

Taysha Gene Therapies Inc (NASDAQ: TSHA) Prices Could Soar To Much Higher Levels In Coming Months - Marketing Sentinel

Apr 28, 2025
pulisher
Apr 26, 2025

Geode Capital Management LLC Has $6.18 Million Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Apr 26, 2025
pulisher
Apr 24, 2025

Taysha Gene Therapies Inc (TSHA) Performance and Fundamentals Dashboard tells a completely different story - Sete News

Apr 24, 2025
pulisher
Apr 23, 2025

Keeping an Eye on Taysha Gene Therapies Inc (TSHA) After Insider Trading Activity - knoxdaily.com

Apr 23, 2025
pulisher
Apr 22, 2025

Taysha Gene Therapies Inc [TSHA] stock Initiated by BMO Capital Markets analyst, price target now $5 - dbtnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Discover Fractyl Health And 2 More Promising Penny Stocks - simplywall.st

Apr 22, 2025
pulisher
Apr 21, 2025

Anchoring Your Portfolio: Is TSHA Stock a Safe Harbor? - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

What is going on with Taysha Gene Therapies Inc? Sentiment Analysis - uspostnews.com

Apr 21, 2025
pulisher
Apr 20, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Sold by JPMorgan Chase & Co. - Defense World

Apr 20, 2025
pulisher
Apr 18, 2025

Vanguard Group Inc. Raises Stock Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Apr 18, 2025
pulisher
Apr 15, 2025

Taysha Gene Therapies: Sell Rating On Uncertain Pipeline Prospects And Limited Opportunity - Seeking Alpha

Apr 15, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Raises Holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

Commonwealth Equity Services LLC Purchases 31,000 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

Needham & Company LLC Reaffirms “Buy” Rating for Taysha Gene Therapies (NASDAQ:TSHA) - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Consensus Rating of “Buy” from Brokerages - The AM Reporter

Apr 10, 2025
pulisher
Apr 08, 2025

AskBio Elects Dr. Laura Sepp-Lorenzino Independent Member of Board of Directors - The Manila Times

Apr 08, 2025
pulisher
Apr 08, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Consensus Target Price from Brokerages - Defense World

Apr 08, 2025
pulisher
Apr 04, 2025

Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks

Apr 04, 2025
pulisher
Apr 04, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 04, 2025
pulisher
Apr 04, 2025

Taysha Expands Team: 822,000 Stock Options Awarded in Strategic Growth Move - Stock Titan

Apr 04, 2025
pulisher
Apr 03, 2025

At $1.32 Price, Taysha Gene Therapies Inc (TSHA) Is Sitting And Waiting - stocksregister.com

Apr 03, 2025
pulisher
Mar 31, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 31, 2025
pulisher
Mar 31, 2025

Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet - Benzinga

Mar 31, 2025
pulisher
Mar 31, 2025

Taysha Stock Hits 52-Week Low at $1.17 Amid Challenges By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Taysha Stock Hits 52-Week Low at $1.17 Amid Challenges - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World

Mar 31, 2025
pulisher
Mar 26, 2025

Bank of New York Mellon Corp Acquires 111,989 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Mar 26, 2025
pulisher
Mar 19, 2025

Is Taysha Gene Therapies (TSHA) the Best Short Squeeze Stock to Buy According to Analysts? - Insider Monkey

Mar 19, 2025
pulisher
Mar 19, 2025

10 Best Short Squeeze Stocks to Buy According to Analysts - Insider Monkey

Mar 19, 2025
pulisher
Mar 16, 2025

Taysha Gene Therapies (TSHA) Projected to Post Earnings on Tuesday - The AM Reporter

Mar 16, 2025
pulisher
Mar 14, 2025

Analysts Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.63 - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Taysha Gene Therapies’ SWOT analysis: stock’s potential in Rett syndrome treatment By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 12, 2025

Taysha Gene Therapies’ SWOT analysis: stock’s potential in Rett syndrome treatment - Investing.com Australia

Mar 12, 2025
pulisher
Mar 11, 2025

Taysha Gene Therapies (TSHA) to Release Earnings on Tuesday - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Taysha's Latest Stock Option Grants: Key Details for Institutional Investors - StockTitan

Mar 07, 2025
pulisher
Mar 06, 2025

Alexandria Real Estate Equities, Inc. Elects Claire Aldridge, PhD, to Board of Directors - The Malaysian Reserve

Mar 06, 2025
pulisher
Mar 05, 2025

Rocket Pharmaceuticals, Inc. (RCKT): A Bull Case Theory - Yahoo Finance

Mar 05, 2025
pulisher
Mar 03, 2025

TSHA FY2025 EPS Forecast Raised by Cantor Fitzgerald - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Needham & Company LLC Reaffirms Buy Rating for Taysha Gene Therapies (NASDAQ:TSHA) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Chardan Capital Reiterates Buy Rating for Taysha Gene Therapies (NASDAQ:TSHA) - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

Taysha Gene Therapies’ Positive Earnings Call Highlights - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Positive Outlook for Taysha Gene Therapies: Buy Rating Backed by FDA Progress and Strong Financial Position - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2024 Earnings Call Transcript - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Taysha Gene Therapies, Inc. (TSHA) Reports Q4 Loss, Tops Revenue Estimates - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Taysha Gene Therapies Reports 2024 Financial Results - TipRanks

Feb 27, 2025
pulisher
Feb 26, 2025

Positive Outlook on Taysha Gene Therapies: Promising Developments and Financial Stability - TipRanks

Feb 26, 2025

Taysha Gene Therapies Inc (TSHA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
大文字化:     |  ボリューム (24 時間):